September 2024

FDA Grants Priority Review to SpringWorks Therapeutics’ New Drug for NF1 Patients

CTF was thrilled to recently announce that our long-time partner, SpringWorks Therapeutics, has received FDA Priority Review for mirdametinib, a potential new treatment for NF1-associated plexiform neurofibromas. This marks a significant milestone for patients, particularly adults who currently lack approved therapies. CTF played a key role in the formation of SpringWorks and in driving the drug repositioning strategy that led to this promising development. 

Read More
story2

How Drug Repositioning is Accelerating Treatments for NF Patients

In a recent interview with PharmaPhorum, a leading media platform dedicated to pharmaceutical and biotech innovation, CTF CEO Annette Bakker discussed the game-changing potential of drug repositioning. Drug repositioning—finding new applications for existing drugs—offers a quicker, more cost-effective pathway to potential treatments. 
Read More
story3

Tune in to our upcoming webinar: Talk to Your Child about NF1

Have you struggled with how to talk to your child about their diagnosis of NF1? Or how to answer their questions about NF1? Ashley Cannon, PhD, MS, CGC and her colleagues will share insights on the research behind two new resources developed with CTF to help families navigate important conversations. Join us on September 25th at 3pm ET.
Register Now

Stories of NF: Madeleine L.

stories of nf
A defining moment I had in my NF1 journey was when I was working at a hospital, and I was able to help a mother and her child find the correct waiting room for their appointment. I found out that the daughter and I had the same diagnosis of NF1. I was really fortunate to be there for the mom and also to talk about my diagnosis with someone who could understand.
Read More

Children’s Tumor Foundation 2023 Annual Report Available to Download

The Children’s Tumor Foundation 2023 Annual Report highlights the year’s progress in NF research, awareness, patient support, and the accomplishments of a dedicated NF community. You can view the report online, or download/print the report.
Read More
Facebook
Twitter
Instagram
YouTube
LinkedIn
CTF NEWSFEED   |  DONATE